Fujifilm Pharmaceuticals U.s.a., Inc.
Clinical trials sponsored by Fujifilm Pharmaceuticals U.s.a., Inc., explained in plain language.
-
New liposomal chemotherapy drug shows promise in early trial for advanced cancers
Disease control OngoingThis early-phase study is testing a new form of the chemotherapy drug topotecan, wrapped in a liposome (a tiny fat bubble), to see if it is safe and what dose works best. About 96 adults with advanced solid tumors (including ovarian, cervical, sarcoma, and certain lung and skin c…
Phase: PHASE1 • Sponsor: Fujifilm Pharmaceuticals U.S.A., Inc. • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New combo therapy aims to stall advanced cancers
Disease control OngoingThis study tests an experimental drug (FF-10832) given alone or with pembrolizumab (an immunotherapy) in about 120 adults with advanced lung or bladder cancer that has not responded to standard treatments. The main goals are to check safety and see how long the cancer can be kept…
Phase: PHASE2 • Sponsor: Fujifilm Pharmaceuticals U.S.A., Inc. • Aim: Disease control
Last updated May 04, 2026 16:30 UTC